AbCellera Biologics, Inc. (ABCL)
12.16
+1.54
(+14.56%)
USD |
NASDAQ |
Aug 25, 14:32
AbCellera Biologics Total Assets (Quarterly) : 1.308B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.308B |
| March 31, 2026 | 1.307B |
| December 31, 2025 | 1.357B |
| September 30, 2025 | 1.356B |
| June 30, 2025 | 1.402B |
| March 31, 2025 | 1.344B |
| December 31, 2024 | 1.361B |
| September 30, 2024 | 1.393B |
| June 30, 2024 | 1.412B |
| March 31, 2024 | 1.463B |
| December 31, 2023 | 1.488B |
| September 30, 2023 | 1.512B |
| June 30, 2023 | 1.537B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.498B |
| December 31, 2022 | 1.541B |
| September 30, 2022 | 1.552B |
| June 30, 2022 | 1.594B |
| March 31, 2022 | 1.592B |
| December 31, 2021 | 1.319B |
| September 30, 2021 | 1.173B |
| June 30, 2021 | 1.152B |
| March 31, 2021 | 1.129B |
| December 31, 2020 | 1.006B |
| September 30, 2020 | 142.39M |
| June 30, 2020 | 155.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 11.08B |
| Danaher Corp. | 92.37B |
| Illumina, Inc. | 6.65B |
| Bio-Techne Corp. | 2.587B |
| Waters Corp. | 24.75B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 233.30M |
| Shareholders Equity (Quarterly) | 896.02M |
| Debt to Equity Ratio | 0.1514 |
| Current Ratio | 12.77 |
| Net Debt Paydown Yield | -0.56% |